Cross Cat Co (2307) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
5 Aug, 2026Executive summary
Net sales for the three months ended June 30, 2026, were ¥4,645 million, up 17.4% year-over-year.
Operating profit rose 41.6% to ¥484 million compared to the same quarter last year.
Ordinary profit increased 40.7% to ¥520 million year-over-year.
Profit attributable to owners of parent was ¥325 million, up 7.5% year-over-year.
Financial highlights
Comprehensive income for the quarter was ¥323 million, nearly flat year-over-year.
Basic earnings per share for the quarter were ¥23.25, compared to ¥21.55 a year ago.
Equity-to-asset ratio improved to 68.3% as of June 30, 2026, from 61.4% at March 31, 2026.
Net assets stood at ¥6,460 million as of June 30, 2026.
Outlook and guidance
Full-year net sales forecast for fiscal year ending March 31, 2027, is ¥17,900 million, up 7.0% year-over-year.
Operating profit is projected at ¥2,150 million, up 6.8% year-over-year.
Profit attributable to owners of parent is forecast at ¥1,540 million, up 1.9% year-over-year.
Basic earnings per share for the full year are expected to be ¥110.03.
Latest events from Cross Cat Co
- Record-high first-half results and double-digit sales growth, with robust sector performance.2307
Q2 202522 Jul 2026 - Record-high revenue and profit for the fourth year, with further growth and returns forecast.2307
Q4 202522 Jul 2026 - Profits and sales rose, driven by financial and public sector growth, with a strong outlook.2307
Q2 202622 Jul 2026 - Record-high revenue and profits for the fifth consecutive year, driven by SI and DX growth.2307
Q4 202622 Jul 2026 - Strong sales and profit growth, higher equity ratio, and treasury share actions marked the quarter.2307
Q1 202522 Jul 2026 - Sales and profits rose on robust IT demand, with improved equity ratio and steady outlook.2307
Q3 202521 Jul 2026 - Profits and margins improved on higher sales and asset gains, with a strong equity ratio and positive outlook.2307
Q1 202621 Jul 2026 - Profits and sales rose, with strong DX growth and improved equity ratio; outlook remains positive.2307
Q3 202621 Jul 2026